(Q38378694)
Statements
Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder (English)
Alonso Montoya
Amaia Hervas
Esther Cardo
María J Mardomingo
José A Alda
María J García-Polavieja
Inmaculada Gilaberte
Rodrigo Escobar